Interactive programme

Relive the course with B. Honton

First day's highlights →
Overview of the second day →
Spotlight on the day 3 →

An interview with…

- Konstantinos Tsioufis - Non-interventionalists and interventionalists need to collaborate for the management of resistant hypertension
- Sebastian Ewen - Talk with experts at RHC
- Thomas Zeller - We need the final data before we can analyse SYMPLICITY HTN-3
- Jean Marco - A personalised approach is vital for managing patients with difficult-to-control hypertension

Download the final programme

  
Speaker
Date
Type

21 sessions found from the search.

Thursday 20th February 2014

Thu, 20 February

14:00 - 14:15

Opening

• Main session

Watch session

14:00 - 14:10
Welcome and introduction of the Course Presentation
F. Mahfoud (GERMANY), K. Tsioufis (GREECE)
14:10 - 14:15
Words from the president of the European Association of Percutaneaous Cardiovascular Interventions Presentation
J. Fajadet (FRANCE)
 

Thu, 20 February

14:15 - 15:30

What are the key mechanisms involved in hypertension?

• Main session

Watch session

Objectives:
  • To understand the key mechanisms involved in hypertension in order to better treat your patient
  • To identify what a personalised approach means
14:30 - 14:35
Introduction Presentation
A. Pathak (FRANCE)
14:35 - 14:40
An elderly patient Presentation
R. Schmieder (GERMANY)
14:40 - 14:55
Discussion
14:55 - 15:00
A metabolic patient Presentation
M. Schlaich (AUSTRALIA)
15:00 - 15:15
Discussion
15:15 - 15:20
A young adrenergic patient Presentation
K. Tsioufis (GREECE)
15:20 - 15:35
Discussion
15:35 - 15:45
Whad did we learn from this session?
F. Mahfoud (GERMANY)
 

Thu, 20 February

16:00 - 17:30

What are the key steps to evaluate a patient with uncontrolled hypertension?

• Main session

Watch session

Objectives:
  • To identify and agree on the key essential steps for an objective diagnostic of an uncontrolled hypertensive patient
  • To share with your peers how to use a comprehensive diagnosis pathway
16:00 - 16:10
Step I - Different modalities to measure blood pressure Presentation
T. Zeller (GERMANY), P.J. Blankestijn (NETHERLANDS)
16:10 - 16:30
Discussion
16:30 - 16:35
Step II - First time examination Presentation
R. Schmieder (GERMANY)
16:35 - 16:45
Discussion
16:45 - 16:55
Step III - Personalised risk assessment Presentation
L. Ruilope (SPAIN)
16:55 - 17:05
Discussion
17:05 - 17:10
Step IV - Adherence to treatment Presentation
M. Burnier (SWITZERLAND)
17:10 - 17:20
Discussion
17:20 - 17:30
What did we learn from this session?
A. Baumbach (UNITED KINGDOM)
 

Thu, 20 February

17:45 - 18:45

Extending clinical evidence with the EnligHTN Renal Denervation system beyond resistant hypertension

• Symposium

With an unrestricted educational grant from SAINT JUDE MEDICAL
Objectives:
  • To understand from the curent evidence which patients best benefit from catheter-based renal sympathetic denervation
  • To appreciate the current level of evidence available on EnligHTN and the pipeline of future clinical studies
  • To learn about the EnligHTN system effectiveness in real-world practice and potential future indications
17:45 - 17:50
Introduction and objectives
K. Tsioufis (GREECE)
17:50 - 17:57
Potential effect of concomitant renal denervation and cardiac ablation in the treatment of atrial Fibrillation
F. Mahfoud (GERMANY)
17:57 - 18:04
Favorable effects of multi-electrode renal sympathetic denervation on left ventricular mass, diastolic function and neurohormonal activation
K. Tsioufis (GREECE)
18:04 - 18:11
Renal sympathetic denervation for the treatment of metabolic syndrome associated hypertension
P.J. Blankestijn (NETHERLANDS)
18:11 - 18:26
The EnligHTN clinical evidence series and the EnligHNTment trial
M. Böhm (GERMANY)
18:26 - 18:40
How to treat: Performing renal denervation with the EnligHTN system
T. Schmitz (GERMANY)
18:40 - 18:45
Key messages
K. Tsioufis (GREECE)
 

Thu, 20 February

17:45 - 19:15

Set-up and optimise a renal denervation programme in your site

• RHClub

Objectives:
  • to discuss how to set-up and optimise a renal denervation programme in your site. Following issues will be shared:
  • Cost effectiveness
  • Patient selection
  • Tools and techniques

Friday 21st February 2014

Fri, 21 February

09:00 - 10:30

Challenges and complications during a procedure

• RHClub

Objectives:
  • to discuss on potential procedural challenges in the cathlab:
  • Complex anatomies
  • Procedural complications
  • Others...

Fri, 21 February

09:00 - 10:00

Renal denervation – Insights and directions

• Symposium

Watch session

With an unrestricted educational grant from BOSTON SCIENTIFIC
Objectives:
  • To learn how the pre-clinical and clinical evidence for catheter-based renal sympathetic denervation is continuing to be built
  • To explore anatomical considerations in patient selection
  • To understand the importance multidisciplinary working in establishing appropriate and sustainable patient pathways
09:00 - 09:05
Introduction and objectives
T.F. Lüscher (SWITZERLAND)
09:05 - 09:17
Anatomic and device considerations
F. Mahfoud (GERMANY)
09:17 - 09:24
Discussion
09:24 - 09:36
Insights from current data
J. Daemen (NETHERLANDS)
09:36 - 09:43
Discussion
09:43 - 09:55
Building sustainable pathways
J. Weil (GERMANY)
09:55 - 10:00
Key messages
T.F. Lüscher (SWITZERLAND)
 

Fri, 21 February

10:15 - 11:45

How to personalise combination therapy

• Main session

Watch session

Objectives:
  • To understand what could be the different possible antihypertensive drug combinations for one individual patient
10:15 - 10:20
Our elderly patient Presentation
R. Schmieder (GERMANY)
10:20 - 10:40
Discussion
10:40 - 10:45
Our metabolic patient Presentation
L. Ruilope (SPAIN)
10:45 - 11:05
Discussion
11:05 - 11:10
Our young adrenergic patient Presentation
M. Schlaich (AUSTRALIA)
11:10 - 11:30
Discussion
11:30 - 11:40
Reaching a consensus all together
F. Mahfoud (GERMANY)
11:40 - 11:45
What did we learn from this session?
M. Lobo (UNITED KINGDOM)
 

Fri, 21 February

12:00 - 13:30

The difficult to manage patients

• RHClub

Objectives:
  • to share your own experience with difficult to manage patients:
  • Non-adherence
  • Drug intolerance
  • Multiple comorbilities
  • Others...

Fri, 21 February

12:00 - 13:00

Transforming the treatment of hypertension, the Symple Way

• Symposium

With an unrestricted educational grant from MEDTRONIC
Objectives:
  • To know how Medtronic continues to innovate and brings value to the technical aspects of the renal denervation procedure
  • To learn how the Symplicity renal denervation systems provide safe and sustained clinical results in a real-world global setting
  • To know what it takes to set-up a successful renal denervation programme
12:00 - 12:05
Introduction
F. Mahfoud (GERMANY)
12:05 - 12:17
HTN-3 / ABPM
R. Schmieder (GERMANY)
12:17 - 12:29
Spyral clinical experience
T. Zeller (GERMANY)
12:29 - 12:41
Data in the real world
F. Mahfoud (GERMANY)
12:41 - 12:53
Setting up a successful hypertension practice
F. Sharif (IRELAND)
12:53 - 13:00
Key messages
R. Schmieder (GERMANY)
 

Fri, 21 February

13:30 - 15:00

How to identify and treat common causes of secondary hypertension - Part I

• Main session

Objectives:
  • To identify and treat renal artery diseases
  • To better understand how to use duplex and 3-dimensional imaging modalities to diagnose secondary causes of hypertension
13:30 - 13:35
Introduction
T. Zeller (GERMANY)
13:35 - 13:45
Diagnosis by duplex on-stage
T. Zeller (GERMANY), U. Beschorner (GERMANY)
13:45 - 13:55
Diagnosis by duplex
U. Beschorner (GERMANY)
13:55 - 14:05
Discussion
14:05 - 14:15
Role of CT / MRI in screening for secondary hypertension
M. Sapoval (FRANCE)
14:15 - 14:25
Case on renal artery diseases - CTA
T. Zeller (GERMANY)
14:25 - 14:35
What do we learn from CORAL and ASTRAL?
J. Radermacher (GERMANY)
14:35 - 14:55
Case on renal artery diseases - FMD
T. Zeller (GERMANY)
14:55 - 15:00
What did we learn from this session?
T. Schmitz (GERMANY)
 

Fri, 21 February

15:30 - 17:00

How to identify and treat common causes of secondary hypertension- Part II

• Main session

Objectives:
  • To appreciate how to identify and treat potential hypertension related to hyperaldosteronism, obstructive sleep apnea or nephropathy
15:30 - 15:40
Our young patient presenting with suspected hyperaldosteronism
O. Vonend (GERMANY)
15:40 - 15:50
Discussion
15:50 - 16:00
Our obese patient presenting with suspected obsctructive sleep apnea
A. Januszewicz (POLAND)
16:00 - 16:10
Discussion
16:10 - 16:20
Our elderly patient presenting with nephropathy
R. Schmieder (GERMANY)
Discussion
16:30 - 16:45
What did I learn? The voice of the young practitioner
S. Ewen (GERMANY)
16:45 - 17:00
Sum-up of screening process / check list
M. Lobo (UNITED KINGDOM)
 

Fri, 21 February

17:15 - 18:15

Renal denervation technical challenges

• Symposium

With an unrestricted educational grant from TERUMO
Objectives:
  • To understand current challenges of renal denervation and solutions
  • To experience a new approach in radial renal denervation
  • To discuss latest techniques and technologies in radial access
17:15 - 17:18
Introduction and objectives
J. Fajadet (FRANCE)
17:18 - 17:32
Technical challenges of renal denervation and potential solutions
T. Zeller (GERMANY)
17:32 - 17:46
Case 1
B. Honton (FRANCE)
17:46 - 17:52
Discussion
17:52 - 18:06
Case 2
E. Garcia (SPAIN)
18:06 - 18:12
Discussion
18:12 - 18:15
Key Messages
J. Fajadet (FRANCE)
 

Fri, 21 February

17:15 - 18:45

Set-up and optimise a renal denervation programme in your site

• RHClub

Objectives:
  • to discuss how to set-up and optimise a renal denervation programme in your site. Following issues will be shared:
  • Cost effectiveness
  • Patient selection
  • Tools and techniques

Saturday 22nd February 2014

Sat, 22 February

07:45 - 09:15

The difficult to manage patients

• RHClub

Objectives:
  • to share your own experience with difficult to manage patients:
  • Non-adherence
  • Drug intolerance
  • Multiple comorbilities
  • Others...

Sat, 22 February

07:45 - 08:45

Resistant hypertension: advancing innovations in open-irrigated catheter ablation

• Symposium

With an unrestricted educational grant from CORDIS
Objectives:
  • To understand the biophysics of radiofrequency ablation in the renal arteries
  • To understand the biophysics of open-irrigated radiofrequency ablation
07:45 - 07:50
Introduction, welcome and agenda review
F. Mahfoud (GERMANY)
07:50 - 08:05
The helical open-irrigated approach: from concept to pre-clinical
F. Mahfoud (GERMANY)
08:05 - 08:20
Expected clinical benefits of catheter-based irrigated ablation
C. Jilek (GERMANY)
08:20 - 08:35
Renal denervation in the multi-disciplinary clinical practice
P.J. Blankestijn (NETHERLANDS)
08:35 - 08:45
Debate, questions and answers
F. Mahfoud (GERMANY)
 

Sat, 22 February

09:00 - 10:30

Device-based therapies targeting the sympathetic system - Part I

• Main session

Objectives:
  • to identify which patient to refer for renal denervation
  • To understand all you need to know on the techniques of renal denervation
  • To better evaluate which is the optimal peri-procedural management
09:00 - 09:05
Review of the screening process
M. Lobo (UNITED KINGDOM)
09:05 - 09:15
Which patient?
F. Mahfoud (GERMANY)
09:15 - 09:25
Effects of ablation
C. Ukena (GERMANY)
09:25 - 09:45
Vessix Boston
J. Fajadet (FRANCE)
09:45 - 09:55
OCT: peri-procedural management
T.F. Lüscher (SWITZERLAND)
09:55 - 10:15
Symplicity Flex and Spyral Medtronic
T. Zeller (GERMANY)
10:15 - 10:30
RenLane Cordis
F. Mahfoud (GERMANY)
 

Sat, 22 February

10:45 - 12:15

Device-based therapies targeting the sympathetic system - Part II

• Main session

Objectives:
  • To understand all you need to know on the techniques of renal denervation
  • To have an overview on other and future devices
  • To learn how to avoid and manage complications
10:45 - 11:05
EnligHTN St. Jude Medical
K. Tsioufis (GREECE)
11:05 - 11:25
Iberis Terumo
J. Fajadet (FRANCE)
11:25 - 11:45
Paradise ReCor Medical
J. Daemen (NETHERLANDS)
11:45 - 12:00
Safety and complications
C. Ukena (GERMANY)
12:00 - 12:15
Future of devices
F. Mahfoud (GERMANY)
 

Sat, 22 February

12:30 - 13:30

Paradise - A novel ultrasound-based approach for renal denervation

• Symposium

With an unrestricted educational grant from RECOR
Objectives:
  • To learn about a novel ultrasound-based approach for performing renal denervation (Paradise) including the latest clinical data and future innovations
  • To gain an understanding of the technical differences between non-focused ultrasound energy and the other existing radiofrequency-based approaches
  • To see how the technical differences with ultrasound translates into safety and efficacy results in the pre-clinical model
12:30 - 12:33
Introduction
T. Zeller (GERMANY)
12:33 - 12:47
The advantages of non-focused ultrasound energy for renal denervation
F. Mahfoud (GERMANY)
12:47 - 13:01
The pathophysiological view: the effects of ultrasound energy in the renal arteries
A. Pathak (FRANCE)
13:01 - 13:15
Clinical results and future innovations with the Paradise system
T. Zeller (GERMANY)
13:15 - 13:25
Discussion
13:25 - 13:30
Key messages
M. Sapoval (FRANCE)
 

Sat, 22 February

13:45 - 14:45

What are the clinical challenges and future indications of renal denervation?

• Main session

Objectives:
  • To reflect on the published data
  • To understand what are the gaps of knowledge and potential future indications
13:45 - 14:00
Critical appraisal of published data
T.F. Lüscher (SWITZERLAND)
14:00 - 14:10
Gaps of knowledge
G. Mancia (ITALY)
14:10 - 14:25
Discussion
14:25 - 14:35
Future of indications
A. Kirtane (USA)
14:35 - 14:45
Discussion
 

Sat, 22 February

14:45 - 15:00

Closing

• Main session

14:45 - 15:00
Closing
F. Mahfoud (GERMANY), K. Tsioufis (GREECE)